Malignant neoplasm of cerebral ventricle
ICD-10 C71.5 is a billable code used to indicate a diagnosis of malignant neoplasm of cerebral ventricle.
C71.5 refers to a malignant neoplasm located in the cerebral ventricle, which is a critical component of the central nervous system (CNS). These tumors can arise from various cell types, including glial cells, ependymal cells, and other neural tissues. The cerebral ventricles are fluid-filled cavities within the brain that play a vital role in the production and circulation of cerebrospinal fluid (CSF). Malignant neoplasms in this area can lead to significant neurological deficits due to their impact on CSF flow and brain function. Symptoms may include headaches, seizures, cognitive changes, and motor deficits, depending on the tumor's size and location. Imaging studies, particularly MRI, are essential for diagnosis, allowing for visualization of the tumor's characteristics and its effects on surrounding brain structures. Molecular markers, such as IDH mutations and 1p/19q co-deletion status, can provide prognostic information and guide treatment decisions. Treatment typically involves a multidisciplinary approach, including surgery, radiation therapy, and chemotherapy, tailored to the tumor's specific characteristics and the patient's overall health.
Detailed operative reports, imaging studies, and pathology results.
Surgical resection of a tumor, post-operative complications, and follow-up imaging.
Ensure accurate coding of tumor size, location, and histology.
Comprehensive treatment plans, including chemotherapy and radiation therapy details.
Management of tumor recurrence, side effects of treatment, and palliative care.
Documentation of molecular markers and response to treatment is crucial.
Used when a patient undergoes surgery for a malignant neoplasm of the cerebral ventricle.
Operative report detailing the procedure, tumor type, and any complications.
Neurosurgeons must document the extent of resection and any intraoperative findings.
MRI is the preferred imaging modality for diagnosing malignant neoplasms of the cerebral ventricle, providing detailed images of the tumor and its effects on surrounding structures.
Molecular markers can provide prognostic information and guide treatment decisions, such as the use of targeted therapies or chemotherapy regimens.
